I believe what madcity is looking at is the 5 most recent data points the show a slight decline. Does anyone know when pradaxa launched? We may be seeing some erosion with the bridging patients I have mentioned in previous posts. That will be high dose syringes. I.e. Less scripts in HD enoxaparin due to pradaxa scripts.